135 related articles for article (PubMed ID: 31375148)
1. Condom use to enhance regression of cervical intraepithelial neoplasia: study protocol for a randomized controlled trial.
Skorstengaard M; Suhr J; Lynge E
Trials; 2019 Aug; 20(1):473. PubMed ID: 31375148
[TBL] [Abstract][Full Text] [Related]
2. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial.
Hogewoning CJ; Bleeker MC; van den Brule AJ; Voorhorst FJ; Snijders PJ; Berkhof J; Westenend PJ; Meijer CJ
Int J Cancer; 2003 Dec; 107(5):811-6. PubMed ID: 14566832
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
5. Role of
Kremer WW; Berkhof J; Bleeker MC; Heideman DA; van Trommel NE; van Baal MW; Verhoeve HR; Meijer CJ; Kenter GG
BMJ Open; 2019 Jul; 9(7):e029017. PubMed ID: 31289088
[TBL] [Abstract][Full Text] [Related]
6. Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
Sand FL; Kjaer SK; Frederiksen K; Dehlendorff C
Int J Cancer; 2020 Aug; 147(3):641-647. PubMed ID: 31648368
[TBL] [Abstract][Full Text] [Related]
7. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
[TBL] [Abstract][Full Text] [Related]
8. Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression.
Munk AC; Gudlaugsson E; Ovestad IT; Lovslett K; Fiane B; Hidle Bv; Kruse AJ; Skaland I; Janssen EA; Baak JP
Gynecol Oncol; 2012 Dec; 127(3):489-94. PubMed ID: 23017821
[TBL] [Abstract][Full Text] [Related]
9. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
10. Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
Garland SM; Paavonen J; Jaisamrarn U; Naud P; Salmerón J; Chow SN; Apter D; Castellsagué X; Teixeira JC; Skinner SR; Hedrick J; Limson G; Schwarz TF; Poppe WA; Bosch FX; de Carvalho NS; Germar MJ; Peters K; Del Rosario-Raymundo MR; Catteau G; Descamps D; Struyf F; Lehtinen M; Dubin G;
Int J Cancer; 2016 Dec; 139(12):2812-2826. PubMed ID: 27541373
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
12. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
[TBL] [Abstract][Full Text] [Related]
13. Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3.
Munk AC; Gudlaugsson E; Malpica A; Fiane B; Løvslett KI; Kruse AJ; Øvestad IT; Voorhorst F; Janssen EA; Baak JP
PLoS One; 2012; 7(9):e45114. PubMed ID: 23028792
[TBL] [Abstract][Full Text] [Related]
14. Performance of HPV E4 and p16
Damgaard RK; Jenkins D; de Koning MN; Quint WG; Stoler MH; Doorbar J; Kahlert J; Gravitt PE; Steiniche T; Petersen LK; Hammer A
BMJ Open; 2022 Jul; 12(7):e059593. PubMed ID: 35793925
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2.
Koeneman MM; Hendriks N; Kooreman LF; Winkens B; Kruitwagen RF; Kruse AJ
Int J Gynecol Cancer; 2019 Jul; 29(6):1003-1009. PubMed ID: 31079058
[TBL] [Abstract][Full Text] [Related]
16. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
Castellsagué X; Paavonen J; Jaisamrarn U; Wheeler CM; Skinner SR; Lehtinen M; Naud P; Chow SN; Del Rosario-Raymundo MR; Teixeira JC; Palmroth J; de Carvalho NS; Germar MJ; Peters K; Garland SM; Szarewski A; Poppe WA; Romanowski B; Schwarz TF; Tjalma WA; Bosch FX; Bozonnat MC; Struyf F; Dubin G; Rosillon D; Baril L;
BMC Infect Dis; 2014 Oct; 14():551. PubMed ID: 25927224
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women.
Catarino R; Vassilakos P; Tebeu PM; Schäfer S; Bongoe A; Petignat P
Cancer Epidemiol; 2016 Feb; 40():60-6. PubMed ID: 26625088
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
19. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
[TBL] [Abstract][Full Text] [Related]
20. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]